Page last updated: 2024-12-06

bunaftine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Bunaftine is a synthetic derivative of the natural alkaloid yohimbine. It acts as a selective α2-adrenergic receptor antagonist, meaning it blocks the action of norepinephrine and epinephrine at these receptors. This property has made bunaftine a subject of research for its potential therapeutic applications. Studies have explored its effects on various conditions, including: 1. Depression: Bunaftine has shown promise in preclinical studies as a potential antidepressant, 2. Erectile dysfunction: Due to its ability to relax blood vessels, it has been investigated for its potential to improve erectile function. 3. Pain management: Bunaftine's interaction with α2-adrenergic receptors suggests possible analgesic effects. 4. Cognitive function: Research is ongoing to assess its potential role in enhancing cognitive performance. However, bunaftine is not currently approved for any clinical use and further research is needed to determine its safety and efficacy in humans.'

Bunaftine: N-Butyl-N-(2-(diethylamino)ethyl)-1-naphthamide. A proposed antiarrhythmic that prolongs myocardial refractory period and stabilizes cell membranes. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID36131
CHEMBL ID2104200
CHEBI ID135392
SCHEMBL ID309282
MeSH IDM0003025

Synonyms (32)

Synonym
brn 2468082
bunaftine
n-butyl-n-(2-(diethylamino)ethyl)-1-naphthamide
bunaftine [inn]
bunaphtine
bunaftide
n-butyl-n-(2-(diethylamino)ethyl)-1-naphthalenecarboxamide
1-naphthalenecarboxamide, n-butyl-n-(2-(diethylamino)ethyl)-
einecs 251-027-1
bunaphtide
bunaftinum [inn-latin]
bunaftina [inn-spanish]
D07428
32421-46-8
bunaftine (inn)
CHEBI:135392
bunaftina
unii-gh09prq3fu
bunaftinum
gh09prq3fu ,
bunaftine [who-dd]
bunaftine [mi]
CHEMBL2104200
SCHEMBL309282
DTXSID90186165
n-butyl-n-[2-(diethylamino)ethyl]naphthalene-1-carboxamide
CS-7150
HY-U00113
DB13652
Q851942
bunaftine; bunaphtide; meregon
AKOS040732680

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
naphthalenecarboxamideAny member of the class of naphthalenes in which the naphthalene ring is directly attached to the carbonyl carbon of a carboxamide group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-199020 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.27 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.55%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (4.55%)4.05%
Observational0 (0.00%)0.25%
Other20 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]